Mount Sinai Launches Phase III Clinical Trial of Novel, Personalized Vaccine for Newly-Diagnosed Kidney Cancer
April 17, 2013
Study will examine potential of investigational immunotherapy AGS-003 to improve survival when combined with standard kidney cancer treatment.
New Six-Gene Signature Can Predict Prostate Cancer Survival
October 9, 2012
Mount Sinai researchers have identified a six-gene model that determines prognosis in men with treatment-resistant prostate cancer.
Mount Sinai Researchers Present Studies On Treatment Trends, Myeloma Vaccine, and Predictive Models at Cancer Meeting
May 17, 2012
Access to care, vaccine, treatment trends among landmark research at the 2012 American Society of Clinical Oncology meeting.
Mount Sinai Partners With National Black Church Initiative to Raise Awareness of Breast and Prostate Cancer
November 12, 2010
Mount Sinai is working with the NBCI to raise awareness in the African-American community of breast and prostate cancer treatment options.
The Mount Sinai Medical Center Names New Vice-Chair of Department of Urology
October 15, 2010
David B. Samadi, MD, chief of robotics, is named vice-chair. An expert in robotic prostate surgery, Dr. Samadi specializes in urologic cancers.
Robotic Prostatectomy Minimizes Surgery, Reduces Recovery Time, and Shortens Hospital Stays
April 15, 2010
Recent Mount Sinai study shows significant benefits to robotically assisted procedures over open prostate surgery.
Can Multimedia Lead to More Informed Decisions on Prostate Cancer Treatment?
March 11, 2010
Mount Sinai School of Medicine leads a study on whether multimedia materials help prostate cancer patients make treatment decisions.
Mount Sinai School of Medicine Significantly Improves Its U.S. News & World Report Best Graduate Schools Rankings
April 24, 2009
Over the past four years, Mount Sinai has improved in the U.S. News & World Report "America's Best Graduate Schools" rankings more than any other school in the United States, jumping from 32nd to 22nd.